Browse
Search
Agenda 10-21-2025; 8-d - Approval of an Amendment to the Freedom House FY 2024-25 Contract for Opioid Funding
OrangeCountyNC
>
Board of County Commissioners
>
BOCC Agendas
>
2020's
>
2025
>
Agenda - 10-21-2025 Business Meeting
>
Agenda 10-21-2025; 8-d - Approval of an Amendment to the Freedom House FY 2024-25 Contract for Opioid Funding
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
10/16/2025 11:58:21 AM
Creation date
10/16/2025 1:41:58 PM
Metadata
Fields
Template:
BOCC
Date
10/21/2025
Meeting Type
Business
Document Type
Agenda
Agenda Item
8-d
Document Relationships
Agenda for October 21, 2025 BOCC Meeting
(Message)
Path:
\Board of County Commissioners\BOCC Agendas\2020's\2025\Agenda - 10-21-2025 Business Meeting
ORD-2025-035-Approval of Amendments to the Orange County Code of Ordinances Section 28 – Personnel Regarding Law Enforcement Special Separation Allowance
(Message)
Path:
\Board of County Commissioners\Ordinances\Ordinance 2020-2029\2025
RES-2025-053-Public Hearing and Resolution for Orange County to Participate in the North Carolina commercial property
(Message)
Path:
\Board of County Commissioners\Resolutions\2020-2029\2025
RES-2025-054-Approval of Amendments to the Orange County Code of Ordinances Section 28
(Message)
Path:
\Board of County Commissioners\Resolutions\2020-2029\2025
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
19
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
14 <br /> Exhibit B <br /> 2. Evidence-Based Treatment <br /> Start Date: 7/1/2024 <br /> Insert Start and End Date forth is Strategy(MM/DD/YYYY) <br /> End Date: 6/30/2025 <br /> Process measures answer the question,"How much did you do?".Please quantify the process measures relevant to your implementation of this strategy.Indicate whether the <br /> count represents efforts supported only by opioid settlement funds or efforts supported by multiple funding sources including opioid settlement funds.Process measures <br /> should reflect numbers from the 2024 fiscal year(i.e.,July 1,2024-June 30,2025). <br /> STRATEGY-SPECIFIC PROCESS MEASURES <br /> Description I Count I How were efforts supported? Notes Additional Information&Helpful Hints about this Measure <br /> 4 of naloxone kits distributed I 1A naloxone kit contains two doses. <br /> 4 of OTPs that dispense methadone,buprenorphine,and naltrexone <br /> 4 of OTPs that dispense only methadone <br /> k of OTP-based medical providers who prescribe methadone for OUD A provider may participate in multiple support programs so there may be <br /> patients some duplication of 4 of providers. <br /> 4 of referrals to opioid treatment programs Number of referrals do not equate to number of unique patients because <br /> one individual may receive multiple referrals. <br /> A unique patient may participate in multiple treatment programs so there <br /> may be some duplication of unique patients when numbers across <br /> k of unique patients with OUD served at OTP programs,project,sites,etc.,are aggregated for the strategy-specific <br /> impact report.A patient may receive services across local government <br /> boundaries(e.g.,a person with OUD may reside in one county and receive <br /> services in another county). <br /> 4 of office-based clinics offering MOUD within county <br /> 4 of individual OBOT providers who prescribe buprenorphine for A provider may participate in multiple support programs so there may be <br /> patients some duplication of 4 of providers. <br /> 4 of buprenorphine prescriptions provided at OBOT <br /> 4 of naltrexone doses provided at OBOT <br /> 4 of referrals to OBOT Number of referrals do not equate to number of unique patients because <br /> one individual may receive multiple referrals. <br /> A unique patient may participate in multiple treatment programs so there <br /> may be some duplication of unique patients when numbers across <br /> It of unique patients with OUD served at OBOT programs,project,sites,etc.,are aggregated forthe strategy-specific <br /> impact report.A patient may receive services across local government <br /> boundaries(e.g.,a person with OUD may reside in one county and receive <br /> services in another county). <br /> 4 of FQHCs offering MOUD within county <br /> 4 of individual FQHC providers who prescribe buprenorphine for A provider may participate in multiple support programs so there may be <br /> patients some duplication of 4 of providers. <br /> 4 of buprenorphine prescriptions provided at FQHC <br /> 4 of naltrexone doses provided at FQHC <br /> 4 of referrals to FQHC MAT services Number of referrals do not equate to number of unique patients because <br /> one individual may receive multiple referrals. <br /> A unique patient may participate in multiple treatment programs so there <br /> may be some duplication of unique patients when numbers across <br /> 4 of unique patients with OUD served at FQHC programs,project,sites,etc.,are aggregated for the strategy-specific <br /> impact report.A patient may receive services across local government <br /> boundaries(e.g.,a person with OUD may reside in one county and receive <br /> services in another county). <br /> 4 of hospitals offering in-patient MOUD within county <br /> 4 of hospitalists who prescribe buprenorphine for patients A provider may participate in multiple support programs so there may be <br /> some duplication of 4 of providers. <br /> If of buprenorphine prescriptions provided through in-patient services <br /> in hospitals <br /> 4 of naltrexone doses provided through in-patient services in hospitals <br />
The URL can be used to link to this page
Your browser does not support the video tag.